Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: A report from the children's oncology group
Document Type
Journal Article
Publication Date
2010
Journal
Clinical Cancer Research
Volume
16
Issue
2
Inclusive Pages
750-754
Keywords
Pediatrics
APA Citation
Jacobs, S., Fox, E., Krailo, M., Hartley, G., & Navid, F. (2010). Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: A report from the children's oncology group. Clinical Cancer Research, 16 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/5119
COinS